Winship M Douglas 4
4 · CATALYST PHARMACEUTICAL PARTNERS, INC. · Filed Dec 14, 2012
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Award
Options to purchase common stock
2012-12-12+25,000→ 312,500 totalExercise: $0.47From: 2012-12-12Exp: 2017-12-12→ Common Stock (25,000 underlying) - Award
Options to purchase common stock
2012-12-12+25,000→ 337,500 totalExercise: $0.47From: 2013-12-12Exp: 2017-12-12→ Common Stock (25,000 underlying) - Award
Options to purchase common stock
2012-12-12+25,000→ 362,500 totalExercise: $0.47From: 2014-12-12Exp: 2017-12-12→ Common Stock (25,000 underlying)